Stock Forecast

  Merit Medical Systems, Inc. ( MMSI) Stock. Should you Buy or Sell?    $ 61.45

0.41 (0.66 %)

Merit Medical Systems, Inc. Analysis

Updated on 10-09-2022
Symbol MMSI
Price $61.45
Beta 1.017
Volume Avg. $347.03 thousand
Market Cap $3.49 B
52 Week Range $50.46 - $73.81

Merit Medical Systems, Inc. opened the day at $61.45 which is +'0.66 % on yesterday's close. Merit Medical Systems, Inc. has a 52 week high of $73.81 and 52 week low of $50.46, which is a difference of $23.35. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $3.49 B and total net profit is $1074751000 which means the company is trading at 3.25 times profit to market capitalization. Theoretically, if you were to buy Merit Medical Systems, Inc. for $3.49 B, it would take 15 years to get your money back. Merit Medical Systems, Inc. are in the Medical Instruments & Supplies space which will have a sweet spot and industry standard for net profit multiples.

Price Chart

1 D | All


Merit Medical Systems, Inc. Stock Forecast - Is Merit Medical Systems, Inc. a Buy or Sell?

DCF ScoreStrong Buy
ROE ScoreNeutral
ROA ScoreNeutral
DE ScoreBuy
PE ScoreStrong Buy
PB ScoreStrong Buy
Overall RecommendationStrong Buy

Growth and Value

PE Ratio 60.842
Dividend Yiel 0.000
Net Profit Margin 0.052

Valuing Merit Medical Systems, Inc.

Price Book Value Ratio 3.246 Price To Book Ratio 3.246
Price To Sales Ratio 3.122 Price Earnings Ratio 59.628

How liquid is Merit Medical Systems, Inc.

Current Ratio 2.519
Quick Ratio 1.191


Debt Ratio 0.342 Debt Equity Ratio 0.520
Long Term Debt To Capitalization 0.216 Total Debt To Capitalization 0.228

Latest news about Merit Medical Systems, Inc.

Merit Medical Systems, Inc. (MMSI) CEO Fred Lampropoulos on Q2 2022 Results - Earnings Call Transcript

Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q2 2022 Earnings Conference Call July 27, 2022 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd - Chief Legal Officer & Corporate Secretary Raul Parra - Chief Financial Officer & Treasurer Conference Call Participants Operator Welcome to the Second Quarter of Fiscal Year 2022 Earnings Conference Call for Merit Medical Systems, Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly.

Date : 28/07/2022

Merit Medical Systems to Announce Second Quarter Results on July 27, 2022

SOUTH JORDAN, Utah, July 14, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2022, after the close of the stock market on Wednesday, July 27, 2022.

Date : 14/07/2022

Merit Medical's (MMSI) New Launch to Improve Patient Outcome

Merit Medical's (MMSI) latest launch will likely aid in precisely targeting affected tissues, thereby resulting in more successful surgeries and improved patient outcomes.

Date : 11/07/2022

Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

Date : 11/07/2022

Here's Why Merit Medical (MMSI) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Date : 23/06/2022

About Merit Medical Systems, Inc.

CEO : Mr. Fred Lampropoulos
Sector : Healthcare
Industry : Medical Instruments & Supplies

Website :

Exchange : NASDAQ Global Select

Description :

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

My Newsletter

Sign Up For Updates & Newsletters